Skip to content
Screener

AbbVie ABBV Q1 2026 earnings

Reported April 29, 2026 · Before market open

Revenue$15.0BBeat by $284.6M
EPS$2.65Beat by $0.06
Revenue estimate$14.7B
EPS estimate$2.59
“We are off to an excellent start in 2026, with first-quarter results exceeding our expectations. AbbVie’s key growth drivers continue to deliver strong performance and support our enhanced full-year outlook, We are also generating exciting data and advancing numerous programs across all stages of development. Our pipeline progress and solid business fundamentals position AbbVie for robust long-term growth.”
Robert A. Michael

Next report

Oct 30, 2026 (In 3 weeks)
Revenue estimate$17.3B
EPS estimate$3.86

Financials

Q1 2026

Income statement

See full
Revenue$15.0B+12.4%
Gross profit$10.8B+15.4%
Operating income$4.0B+6.9%
Net income$695.0M-46.0%
EPS (diluted)$0.39-45.8%

Balance sheet

See full
Cash & equivalents$9.4B+81.5%
Total equity-$6.7B-569%
Total assets$136.46B+0.2%

Cash flow

See full
Operating cash flow$3.8B+134%
CapEx$265.0M+12.8%
Free cash flow$3.6B+155%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$384.69B+3.8%
P/E105.8×+17.5×
P/S6.1×-0.3×

Profitability

See full
Gross margin70.7%0.0pp
Operating margin24.4%—
Net margin5.8%-1.5pp
FCF margin31.8%+5.0pp

Returns & leverage

See full
Current ratio0.8×0.0×

Segments

By product

See full
Skyrizi$4.5B+30.9%
Rinvoq$2.1B+23.3%
All other$1.0B-18.2%
Botox Therapeutic$1.0B+16.5%
Vraylar$905.0M+18.3%

FAQ

When did AbbVie report Q1 2026 earnings?
AbbVie (ABBV) reported Q1 2026 earnings on April 29, 2026 before market open.
What were AbbVie's Q1 2026 revenue and EPS?
AbbVie reported revenue of $15.0B and eps of $2.65 for Q1 2026.
Did AbbVie beat estimates in Q1 2026?
Revenue beat the consensus estimate of $14.7B by $284.6M. EPS beat the consensus estimate of $2.59 by $0.06.
How did AbbVie's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.4% from $13.3B a year earlier and eps grew 7.7% from $2.46.
Where can I find AbbVie's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001551152-26-000013) and the 10-Q periodic report (0001551152-26-000017) directly on SEC EDGAR. The filing index links above go to sec.gov.